Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

SHP2: A Potential Therapeutic Agent for MuSK-Myasthenia

Conference paper

Cao M. et al, (2017), ANNALS OF NEUROLOGY, 82, S34 - S34

CASPR2 autoantibodies are raised during pregnancy in mothers of children with mental retardation and disorders of psychological development but not autism

Journal article

Coutinho E. et al, (2017), Journal of Neurology, Neurosurgery & Psychiatry, 88, 718 - 721

Pathogenic potential of antibodies to the GABAB receptor

Journal article

Nibber A. et al, (2017), Epilepsia Open, 2, 355 - 359

Diagnostic algorithm for relapsing acquired demyelinating syndromes in children

Journal article

Hacohen Y. et al, (2017), Neurology, 89, 269 - 278

IgG-specific cell-based assay detects potentially pathogenic MuSK-Abs in seronegative MG

Journal article

Huda S. et al, (2017), Neurology - Neuroimmunology Neuroinflammation, 4, e357 - e357

Screening for antibodies in narcolepsy type 1 and type 2

Conference paper

Giannoccaro MP. et al, (2017), EUROPEAN JOURNAL OF NEUROLOGY, 24, 79 - 79

Redefining progressive encephalomyelitis with rigidity and myoclonus after the discovery of antibodies to glycine receptors

Journal article

Crisp SJ. et al, (2017), Current Opinion in Neurology, 30, 310 - 316

Focal CA3 hippocampal subfield atrophy following LGI1 VGKC-complex antibody limbic encephalitis

Journal article

Miller TD. et al, (2017), Brain, 140, 1212 - 1219

Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies

Journal article

Lang B. et al, (2017), Journal of Neurology, Neurosurgery & Psychiatry, 88, 353 - 361

Pitfalls in the detection of N -methyl- d -aspartate-receptor (NMDA-R) antibodies

Journal article

Gastaldi M. et al, (2017), Clinical Biochemistry, 50, 354 - 355

Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis

Journal article

Jurynczyk M. et al, (2017), Brain, 140, 617 - 627

Focal status epilepticus and progressive dyskinesia: A novel phenotype for glycine receptor antibody-mediated neurological disease in children

Journal article

Chan DWS. et al, (2017), European Journal of Paediatric Neurology, 21, 414 - 417

Pediatric Autoimmune Epileptic Encephalopathies

Journal article

Wright S. and Vincent A., (2017), Journal of Child Neurology, 32, 418 - 428

Serum neuronal cell-surface antibodies in first-episode psychosis–Authors' reply

Other

Lennox BR. et al, (2017), The Lancet Psychiatry, 4, 187 - 188

Do we need to measure specific antibodies in patients with limbic encephalitis?

Journal article

Dalmau J. and Vincent A., (2017), Neurology, 88, 508 - 509

Antibodies Against Hypocretin Receptor 2 Are Rare in Narcolepsy

Journal article

Giannoccaro MP. et al, (2017), Sleep, 40

Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody disease

Journal article

Juryńczyk M. et al, (2017), Journal of Neurology, Neurosurgery & Psychiatry, 88, 132 - 136

Chronic neuropathic pain severity is determined by lesion level in aquaporin 4-antibody-positive myelitis

Journal article

Tackley G. et al, (2017), Journal of Neurology, Neurosurgery & Psychiatry, 88, 165 - 169

First reported cases of anti-NMDA receptor encephalitis in Vietnamese adolescents and adults

Journal article

Nguyen Thi Hoang M. et al, (2017), Journal of the Neurological Sciences, 373, 250 - 253

Load More